Summary: S.1053 — 105th Congress (1997-1998)All Information (Except Text)

There is one summary for S.1053. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (07/22/1997)

Office of National Drug Control Policy Reauthorization Act of 1997 - Amends the National Narcotics Leadership Act of 1988 (the Act) to revise definitions, including by: (1) including within the definition of "demand reduction" activities to reduce the underage use of tobacco or alcoholic beverages; and (2) defining "intergovernmental relations" as domestic activities conducted by a National Drug Control Program agency that are intended to reduce the availability and use of drugs.

Modifies provisions of the Act regarding establishment of the Office of National Drug Control Policy (the Office) to: (1) set forth the responsibilities of such Office (to develop national drug control policy, coordinate and oversee its implementation, assess and certify the adequacy of national drug control programs and budgets, and evaluate their effectiveness); and (2) provide for Deputy Directors of National Drug Control Policy, for International Drug Policy, and for Intergovernmental Relations.

Establishes in the Treasury a fund for the receipt of gifts to aid or facilitate the work of the Office.

Prohibits Federal officers in the Office from participating in Federal election campaign activities, except for making contributions to individual campaigns.

Sets forth or modifies provisions regarding the responsibilities of national drug control program agencies, the drug certification process, and coordination with executive branch departments and agencies in supply and demand reduction and intergovernmental relations.

Amends provisions regarding the National Drug Control Strategy to require: (1) the President to submit to the Congress by February 1, 1997, a Strategy which sets forth a comprehensive ten-year plan for reducing drug abuse and its consequences in the United States by limiting the availability of and reducing the demand for illegal drugs and the first of annual reports on progress in implementing the Strategy; and (2) the Director of National Drug Control Policy to include with the annual Strategy Report a description of the national drug control performance measurement system.

Establishes in the Office a High Intensity Drug Trafficking Areas Program.

Amends provisions regarding the Counter-Drug Technology Assessment Center to have it headed by a Director of Technology and to specify duties of such Director, such as identifying demand reduction basic and applied research needs and initiatives. Requires the Departments of Defense and Health and Human Services to render assistance and support to the Office and its Director in the conduct of counter-drug technology assessment.

Terminates the Office on September 30, 2009. Authorizes appropriations.